Skip to content
Logo text: ISPOR Improving healthcare decisions

Health Technology Assessment Central

The HTA Resource Center for Informing Healthcare Decisions

  • Home
  • What Is HTA?
  • HTA News and Events
  • Resource Library
  • Governance
  • Policy Interchange
  • Training and Development
« Back to ISPOR.org

News

Turning European HTA Reform Into Level for Controlling Drug Developers

June 7, 2018

http://www.appliedclinicaltrialsonline.com/turning-european-hta-reform-level-controlling-drug-developers

Posted in: Uncategorized

Post navigation

← The Commission’s Proposal on Health Technology Assessment – Will the EU Member States Accept its Mandatory Provisions?
English translation of IQWiG’s updated General Methods now available →

News

The new definition of HTA: A milestone in international collaboration
Impact of a Global Pandemic on Health Technology Assessment
NEW HTAi – ISPOR Joint Deliberative Processes for HTA Task Force
Strategic collaboration announced by NICE and Health Technology Wales
NICE and LSE announce new Executive MSc in Evaluation of Health Care Interventions and Outcomes degree program, starting in April 2020
Why HTA and Pooled Purchasing Must Be at the Heart of Global Health Transitions
Health Technology Assessment Around the World: Broadening the Understanding of Cross-Country Differences
Ghana’s HTA agenda and UHC, what difference could HTA make?
AMCP releases the AMCP Format for Formulary Submissions, version 4.1
The ‘Top 10’ Challenges for Health Technology Assessment: INAHTA Viewpoint

Twitter

Tweets about #HTA

#HTA

paulsutcliffewePaul Sutcliffe@paulsutcliffewe·
3h

A very useful read if you are interested in #qualitative research methods and #HTA by @AndrewB007h

Reply on Twitter 1331159965206245377Retweet on Twitter 1331159965206245377Like on Twitter 1331159965206245377Twitter 1331159965206245377
YNatsisYannis Natsis@YNatsis·
3h

#HTA’s Critical Role in the (Early) Assessment of (potential) #Vaccines to prevent the spread of COVID-19 globally
https://htai.org/wp-content/uploads/2020/10/COVID-19-Position-Statement.pdf

Reply on Twitter 1331156288970092547Retweet on Twitter 1331156288970092547Like on Twitter 13311562889700925472Twitter 1331156288970092547
Petelos1Petelos@Petelos1·
6h

@HTAiOrg on #HTA’s Critical Role in (Early) Assessment of (potential) #Vaccines for #COVID19 globally. We intend this to be a living document and welcome feedback from everyone. #Publichealth #Transparency #RWE https://www.linkedin.com/pulse/vaccines-health-technology-assessment-hta-covid-19-pandemic-petelos/ @EUPHA_HTA @HTAiOrg @SItI_HTA

Reply on Twitter 1331115412797403136Retweet on Twitter 1331115412797403136Like on Twitter 1331115412797403136Twitter 1331115412797403136
Load More...
Privacy Policy | Disclaimer
Copyright © 2020 ISPOR – The Professional Society for Health Economics and Outcomes Research